Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$327.98 USD

327.98
1,613,619

+2.68 (0.82%)

Updated Apr 23, 2024 04:00 PM ET

After-Market: $329.27 +1.29 (0.39%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 21% (200 out of 252)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for HUM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Humana Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 21,320 18,942 16,586 17,227 15,026
Receivables 2,035 1,674 1,814 1,138 1,056
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 6,631 5,567 6,493 5,276 3,806
Total Current Assets 29,986 26,183 24,893 23,641 19,888
Net Property & Equipment 3,030 3,221 3,073 2,371 1,955
Investments & Advances 1,122 1,129 921 2,382 1,469
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 9,550 9,142 11,092 4,447 3,928
Deposits & Other Assets 3,377 3,380 4,379 2,128 1,834
Total Assets 47,065 43,055 44,358 34,969 29,074
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 353 298 326 320 225
Accounts Payable 6,569 5,238 4,509 4,013 3,754
Current Portion Long-Term Debt 1,443 2,092 1,953 600 699
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 10,507 9,550 8,543 8,461 6,251
Total Current Liabilities 18,872 17,178 15,331 13,394 10,929
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 10,213 9,034 10,541 6,060 4,967
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,662 1,473 2,383 1,787 1,141
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 30,747 27,685 28,255 21,241 17,037
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 33 33 33 33 33
Capital Surplus 3,346 3,246 3,082 2,705 2,820
Retained Earnings 27,540 25,492 23,086 20,517 17,483
Other Equity -943 -1,245 65 391 156
Treasury Stock 13,658 12,156 10,163 9,918 8,455
Total Shareholder's Equity 16,318 15,370 16,103 13,728 12,037
Total Liabilities & Shareholder's Equity 47,065 43,055 44,358 34,969 29,074
Total Common Equity 16,318 15,370 16,103 13,728 12,037
Shares Outstanding 123.10 126.60 128.50 132.30 132.40
Book Value Per Share 132.56 121.41 125.32 103.76 90.91

Fiscal Year End for Humana Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 21,320 30,293 31,465 28,667
Receivables NA 2,035 1,824 1,429 3,107
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 6,631 6,136 5,865 5,758
Total Current Assets NA 29,986 38,253 38,759 37,532
Net Property & Equipment NA 3,030 3,342 3,309 3,234
Investments & Advances NA 1,122 1,132 1,122 1,110
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 9,550 9,540 9,539 9,320
Deposits & Other Assets NA 3,377 3,638 3,726 3,580
Total Assets NA 47,065 55,905 56,455 54,776
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 353 246 457 406
Accounts Payable NA 6,569 7,600 8,118 7,431
Current Portion Long-Term Debt NA 1,443 2,245 2,022 1,867
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 10,507 17,732 17,682 17,238
Total Current Liabilities NA 18,872 27,823 28,279 26,942
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 10,213 9,483 9,722 9,743
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 1,595 1,563 1,457
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 30,747 38,901 39,564 38,142
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 33 33 33 33
Capital Surplus NA 3,346 3,362 3,313 3,262
Retained Earnings NA 27,540 28,191 27,468 26,619
Other Equity NA -943 -1,448 -1,169 -1,056
Treasury Stock NA 13,658 13,134 12,754 12,224
Total Shareholder's Equity NA 16,318 17,004 16,891 16,634
Total Liabilities & Shareholder's Equity NA 47,065 55,905 56,455 54,776
Total Common Equity 0 16,318 17,004 16,891 16,634
Shares Outstanding 120.60 123.10 123.10 123.90 124.90
Book Value Per Share 0.00 132.56 138.13 136.33 133.18